Details for Patent: 11,433,044
✉ Email this page to a colleague
Which drugs does patent 11,433,044 protect, and when does it expire?
Patent 11,433,044 protects FUROSCIX and is included in one NDA.
This patent has twenty-four patent family members in fifteen countries.
Summary for Patent: 11,433,044
| Title: | Pharmaceutical formulations for subcutaneous administration of furosemide |
| Abstract: | The present teachings relate to liquid pharmaceutical formulations of furosemide, where the pharmaceutical formulations include a molar excess of tris(hydroxymethyl)aminomethane to furosemide, have a pH in the range of 7 to 8.5, and a concentration of tris(hydroxymethyl)aminomethane greater than or equal to about 50 mM. The present teachings can improve the stability of liquid pharmaceutical formulations including furosemide and the suitability of such pharmaceutical formulations for subcutaneous administration or delivery. |
| Inventor(s): | Michaels Scott A., Muntendam Pieter, Larsen Glenn R. |
| Assignee: | scPharmaceuticals Inc. |
| Application Number: | US16295085 |
|
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 11,433,044
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scpharmaceuticals | FUROSCIX | furosemide | SOLUTION;SUBCUTANEOUS | 209988-001 | Oct 7, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | USE OF A LIQUID FORMULATION COMPRISING FUROSEMIDE TO TREAT CONGESTION DUE TO FLUID OVERLOAD (EDEMA) IN ADULTS WITH NYHA CLASS II/III CHRONIC HEART FAILURE | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,433,044
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014248164 | ⤷ Sign Up | |||
| Brazil | 112015025204 | ⤷ Sign Up | |||
| Canada | 2908935 | ⤷ Sign Up | |||
| China | 105431145 | ⤷ Sign Up | |||
| Denmark | 2981258 | ⤷ Sign Up | |||
| European Patent Office | 2981258 | ⤷ Sign Up | |||
| European Patent Office | 3799869 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
